These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2042428)

  • 1. Cytologic detection of urothelial cancer and other abnormalities in a cohort of workers exposed to aromatic amines.
    Crosby JH; Allsbrook WC; Koss LG; Bales CE; Witherington R; Schulte PA; Hemstreet G; Ringer K
    Acta Cytol; 1991; 35(3):263-8. PubMed ID: 2042428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary cytology of tuberculosis of the bladder.
    Piscioli F; Pusiol T; Polla E; Failoni G; Luciani L
    Acta Cytol; 1985; 29(2):125-31. PubMed ID: 3856982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening.
    Marsh GM; Cassidy LD
    Am J Ind Med; 2003 Feb; 43(2):142-8. PubMed ID: 12541268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of denuded urothelium in bladder biopsy.
    Levi AW; Potter SR; Schoenberg MP; Epstein JI
    J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):92-7. PubMed ID: 18162775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.
    Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
    Int J Urol; 2009 Mar; 16(3):293-8. PubMed ID: 19207607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpapillary lesions of the urinary bladder: a retrospective study.
    Schujman E; Mukamel E; Slutzker D; Vilcovsky E; Servadio C
    Isr J Med Sci; 1983 Jul; 19(7):619-25. PubMed ID: 6885346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
    Kryvenko ON; Epstein JI
    J Urol; 2013 Jun; 189(6):2083-6. PubMed ID: 23228381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation.
    Herawi M; Parwani AV; Chan T; Ali SZ; Epstein JI
    Am J Surg Pathol; 2006 Mar; 30(3):345-50. PubMed ID: 16538054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer screening and monitoring of 4,4'-methylenebis(2-chloroaniline) exposure among workers in Taiwan.
    Chen HI; Liou SH; Loh CH; Uang SN; Yu YC; Shih TS
    Urology; 2005 Aug; 66(2):305-10. PubMed ID: 16098360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Occupational cancer of the urinary bladder: the diagnostic value of urinary cytology in dyestuff workers exposed to aromatic amine].
    Matsushima M; Murakami N; Fukazawa K; Yagishita T; Fujio K; Miura K; Sawamura Y; Tajima M; Nakayama K; Shirai M; Ando K
    Nihon Hinyokika Gakkai Zasshi; 1983 Jan; 74(1):81-99. PubMed ID: 6865154
    [No Abstract]   [Full Text] [Related]  

  • 17. Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
    Bi W; Rao JY; Hemstreet GP; Fang P; Asal NR; Zang M; Min KW; Ma Z; Lee E; Li G
    J Occup Med; 1993 Jan; 35(1):20-7. PubMed ID: 7678643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
    Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
    J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
    Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
    J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.